TREATMENT OF THE T3—4N0M0 BREAST CANCER

The aim of the study was to determine the most effective regimens of the neo- and adjuvant therapy of the primary breast cancer of the T3—4N0M0 stages. The data of the clinical observations of the 145 patients with the locally advanced T3—4N0M0 breast cancer, who underwent treatment in the N.N.Blokh...

Full description

Saved in:
Bibliographic Details
Main Authors: K. V. Maximov, I. V. Visotzkaya, V. D. Yermilova, V. P. Letyagin, Ye. M. Pogodina, G. Yu. Chemeris, A. D. Zikiryakhodzhayev, Ye. A. Kim, G. V. Martinova
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Опухоли женской репродуктивной системы
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/332
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403745634353152
author K. V. Maximov
I. V. Visotzkaya
V. D. Yermilova
V. P. Letyagin
Ye. M. Pogodina
G. Yu. Chemeris
A. D. Zikiryakhodzhayev
Ye. A. Kim
G. V. Martinova
author_facet K. V. Maximov
I. V. Visotzkaya
V. D. Yermilova
V. P. Letyagin
Ye. M. Pogodina
G. Yu. Chemeris
A. D. Zikiryakhodzhayev
Ye. A. Kim
G. V. Martinova
author_sort K. V. Maximov
collection DOAJ
description The aim of the study was to determine the most effective regimens of the neo- and adjuvant therapy of the primary breast cancer of the T3—4N0M0 stages. The data of the clinical observations of the 145 patients with the locally advanced T3—4N0M0 breast cancer, who underwent treatment in the N.N.Blokhin CRC over the period of 1998—2003, were used in the study. The mean age of the patients was 55,3±12,9 years (from 19 to 83 years, median-55 years). The duration of the observation of the patients was 46,5±28,51 months (from 3,6 to 109,4 months, median-44,5 months). For patients with the breast cancer of the T3—4N0M0 stages combined treatment modality was implemented with the use of neo- and adjuvant therapy in all the cases.
format Article
id doaj-art-50d18b278b1f4625b439c5f1c2e028ca
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-50d18b278b1f4625b439c5f1c2e028ca2025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-09-0101202410.17650/1994-4098-2008-0-1-20-24348TREATMENT OF THE T3—4N0M0 BREAST CANCERK. V. Maximov0I. V. Visotzkaya1V. D. Yermilova2V. P. Letyagin3Ye. M. Pogodina4G. Yu. Chemeris5A. D. Zikiryakhodzhayev6Ye. A. Kim7G. V. Martinova8N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowThe aim of the study was to determine the most effective regimens of the neo- and adjuvant therapy of the primary breast cancer of the T3—4N0M0 stages. The data of the clinical observations of the 145 patients with the locally advanced T3—4N0M0 breast cancer, who underwent treatment in the N.N.Blokhin CRC over the period of 1998—2003, were used in the study. The mean age of the patients was 55,3±12,9 years (from 19 to 83 years, median-55 years). The duration of the observation of the patients was 46,5±28,51 months (from 3,6 to 109,4 months, median-44,5 months). For patients with the breast cancer of the T3—4N0M0 stages combined treatment modality was implemented with the use of neo- and adjuvant therapy in all the cases.https://ojrs.abvpress.ru/ojrs/article/view/332
spellingShingle K. V. Maximov
I. V. Visotzkaya
V. D. Yermilova
V. P. Letyagin
Ye. M. Pogodina
G. Yu. Chemeris
A. D. Zikiryakhodzhayev
Ye. A. Kim
G. V. Martinova
TREATMENT OF THE T3—4N0M0 BREAST CANCER
Опухоли женской репродуктивной системы
title TREATMENT OF THE T3—4N0M0 BREAST CANCER
title_full TREATMENT OF THE T3—4N0M0 BREAST CANCER
title_fullStr TREATMENT OF THE T3—4N0M0 BREAST CANCER
title_full_unstemmed TREATMENT OF THE T3—4N0M0 BREAST CANCER
title_short TREATMENT OF THE T3—4N0M0 BREAST CANCER
title_sort treatment of the t3 4n0m0 breast cancer
url https://ojrs.abvpress.ru/ojrs/article/view/332
work_keys_str_mv AT kvmaximov treatmentofthet34n0m0breastcancer
AT ivvisotzkaya treatmentofthet34n0m0breastcancer
AT vdyermilova treatmentofthet34n0m0breastcancer
AT vpletyagin treatmentofthet34n0m0breastcancer
AT yempogodina treatmentofthet34n0m0breastcancer
AT gyuchemeris treatmentofthet34n0m0breastcancer
AT adzikiryakhodzhayev treatmentofthet34n0m0breastcancer
AT yeakim treatmentofthet34n0m0breastcancer
AT gvmartinova treatmentofthet34n0m0breastcancer